rss
J Clin Pathol 61:1013-1017 doi:10.1136/jcp.2008.056317
  • Reviews

Complement deficiency and disease

  1. D J Unsworth
  1. Dr D J Unsworth, Department of Immunology and Immunogenetics, Southmead Hospital, Bristol BS10 5ND, UK; joe.unsworth{at}nbt.nhs.uk
  • Accepted 7 April 2008
  • Published Online First 21 May 2008

Abstract

There are approximately 30 serum complement proteins (15% of the globulin fraction), excluding cell surface receptors, and regulatory proteins. Many are manufactured in the liver, and reduced complement is a feature of severe liver failure. Complement proteins contribute to the acute phase response, and high levels are seen in chronic untreated inflammation (eg, rheumatoid arthritis). Once activated, complement is strongly pro-inflammatory. Indeed, almost half of the complement system proteins/receptors play regulatory roles, reflecting the importance of controlling inappropriate activation. This review focuses on disease states arising as a direct consequence of complement deficiency or dysfunction.

Footnotes

  • Competing interests: None.

Latest from JCP Education

Latest from JCP Education

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JCP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest Pathology jobs

Latest Pathology jobs